Bristol-Myers Squibb
BMY
$50.86
Share price
1.09%
Change (1 day)
-35.53%
Change (1 year)
Categories
Number of shares outstanding for Bristol-Myers Squibb (BMY)
Number of shares outstanding as of December 2023 : 2,057,000,000
According to Bristol-Myers Squibb's latest financial reports and stock price the company's current number of shares outstanding is 2,057,000,000. At the end of 2023 the company had 2,057,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Bristol-Myers Squibb from 2001 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 2.05 B | -2.42% |
| 2022 | 2.10 B | -2.09% |
| 2021 | 2.15 B | -4.4% |
| 2020 | 2.25 B | 17.41% |
| 2019 | 1.91 B | 17.52% |
| 2018 | 1.63 B | -0.24% |
| 2017 | 1.63 B | -2.15% |
| 2016 | 1.67 B | 0.18% |
| 2015 | 1.66 B | 0.54% |
| 2014 | 1.66 B | 0.73% |
| 2013 | 1.64 B | 0.24% |
| 2012 | 1.64 B | -2.78% |
| 2011 | 1.69 B | -0.94% |
| 2010 | 1.70 B | -12.86% |
| 2009 | 1.95 B | -1.06% |
| 2008 | 1.98 B | 0.2% |
| 2007 | 1.97 B | 0.66% |
| 2006 | 1.96 B | 0.41% |
| 2005 | 1.95 B | 0.51% |
| 2004 | 1.94 B | 0.26% |
| 2003 | 1.94 B | -11.04% |
| 2002 | 2.18 B | 12.59% |
| 2001 | 1.93 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,407,178,000 | 17.02% | 🇺🇸 USA |
 Novartis NVS | 2,062,000,000 | 0.24% | 🇨🇭 Switzerland |
 Pfizer PFE | 5,646,000,000 | 174.48% | 🇺🇸 USA |
 AbbVie ABBV | 1,767,000,000 | -14.10% | 🇺🇸 USA |
 Eli Lilly LLY | 949,303,000 | -53.85% | 🇺🇸 USA |
 Amgen AMGN | 535,000,000 | -73.99% | 🇺🇸 USA |
 Sanofi SNY | 2,506,400,000 | 21.85% | 🇫🇷 France |
 Biogen BIIB | 144,800,000 | -92.96% | 🇺🇸 USA |
 Merck MRK | 2,535,293,793 | 23.25% | 🇺🇸 USA |
 AstraZeneca AZN | 3,098,000,000 | 50.61% | 🇬🇧 UK |